Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel
An. bras. dermatol
;
95(2): 221-237, Mar.-Apr. 2020. tab, graf
Artículo
en Inglés
| LILACS, ColecionaSUS
| ID: biblio-1130848
ABSTRACT
Abstract With the development of new cancer therapies, systemic toxicity profile and effects on survival achieved an important improvement. However, a constellation of toxicities has emerged, even more remarkably, cutaneous adverse events. This report, developed by a board of Brazilian experts in oncodermatology, aims to establish a guideline for the dermatological care of oncologic patients. When possible, evidence-based recommendations were made, but in many cases, when strong evidence was not available, a consensus was reached, based on some data supporting therapies combined with personal experiences.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Enfermedades de la Piel
/
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
/
Neoplasias
/
Antineoplásicos
Tipo de estudio:
Estudio de etiología
/
Guía de Práctica Clínica
/
Factores de riesgo
Límite:
Humanos
Idioma:
Inglés
Revista:
An. bras. dermatol
Año:
2020
Tipo del documento:
Artículo
Institución/País de afiliación:
Centro Paulista de Oncologia/BR
/
Hospital Beneficência Portuguesa de São Paulo/BR
/
Hospital Sírio-Libanês/BR
/
Santa Casa de Misericórdia de São Paulo/BR
/
Universidade de São Paulo/BR
Similares
MEDLINE
...
LILACS
LIS